TCT 2025: STORM-PE Trial Demonstrates Safety and Efficacy of Mechanical Thrombectomy in Intermediate-High-Risk Pulmonary Embolism
The STOR…
Canadian Lobbyists Represent Major Polluters and Environmental Groups
A new report by FMinus reveals a conflict of interest in Canadian lo…
Research ICT Africa Develops AI Framework for Africa
Research ICT Africa, a non-profit think tank, has created the Just AI Framework of In…
Building the Future, Respecting the Past
Tbilisi is undergoing a dynamic transformation, with sustainable urban development taking center …
Grokipedia Launch and Controversy
Elon Musk's Grokipedia, a rival to Wikipedia, has launched after a brief crash. The website, which claim…
LGBTQ+ Community Center Expands Programming
PRISM LGBTQ+ Community Center in Pottstown is introducing new inclusive programs and support g…
GSK Secures Rights to Syndivia's ADC Asset for Prostate Cancer
GSK has acquired exclusive rights from Syndivia for an ADC targeting advanc…
Giving States Waivers From Accountability Is a Dangerous Step Backward for Kids
By loosening testing and reporting requirements, the Educa…
Novartis to Acquire Avidity Biosciences for US$12 Billion
Novartis will buy Avidity Biosciences for US$12 billion, gaining its RNA-based t…
SELUTION DeNovo Trial Results
The SELUTION DeNovo randomized clinical trial, presented at TCT 2025 in San Francisco, USA, demonstrated non…